

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 4.35476964 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.22162094 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.02819707 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.88774878 |
| 5 | proline transport (GO:0015824) | 3.86867794 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.79660159 |
| 7 | locomotory exploration behavior (GO:0035641) | 3.77278941 |
| 8 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.69260331 |
| 9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.65915239 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 3.59613416 |
| 11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.53081104 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.45220838 |
| 13 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.38237698 |
| 14 | mannose metabolic process (GO:0006013) | 3.37442755 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.28713837 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.28099827 |
| 17 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.27216078 |
| 18 | synaptic vesicle endocytosis (GO:0048488) | 3.16568852 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 3.15975349 |
| 20 | glutamate secretion (GO:0014047) | 3.13296912 |
| 21 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.13057831 |
| 22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.12121230 |
| 23 | modulation by symbiont of host immune response (GO:0052553) | 3.09302394 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 3.09302394 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 3.09302394 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.09302394 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.09302394 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.09302394 |
| 29 | nerve growth factor signaling pathway (GO:0038180) | 3.08464334 |
| 30 | protein localization to synapse (GO:0035418) | 3.05057575 |
| 31 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.04579589 |
| 32 | detection of other organism (GO:0098543) | 3.03928751 |
| 33 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.02523883 |
| 34 | regulation of synapse structural plasticity (GO:0051823) | 3.01822401 |
| 35 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.99312468 |
| 36 | daunorubicin metabolic process (GO:0044597) | 2.97447358 |
| 37 | polyketide metabolic process (GO:0030638) | 2.97447358 |
| 38 | doxorubicin metabolic process (GO:0044598) | 2.97447358 |
| 39 | cellular potassium ion homeostasis (GO:0030007) | 2.97210611 |
| 40 | response to muramyl dipeptide (GO:0032495) | 2.95222897 |
| 41 | regulation of ARF protein signal transduction (GO:0032012) | 2.95052173 |
| 42 | negative regulation of cell killing (GO:0031342) | 2.94646316 |
| 43 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.94646316 |
| 44 | detection of bacterium (GO:0016045) | 2.94483377 |
| 45 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.91720105 |
| 46 | synaptic transmission, glutamatergic (GO:0035249) | 2.91036774 |
| 47 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.91026098 |
| 48 | regulation of gamma-delta T cell activation (GO:0046643) | 2.88457911 |
| 49 | vocalization behavior (GO:0071625) | 2.88112756 |
| 50 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.86180387 |
| 51 | B cell receptor signaling pathway (GO:0050853) | 2.83251567 |
| 52 | neurotransmitter secretion (GO:0007269) | 2.82335584 |
| 53 | response to auditory stimulus (GO:0010996) | 2.80791643 |
| 54 | cellular extravasation (GO:0045123) | 2.80085153 |
| 55 | stress fiber assembly (GO:0043149) | 2.78716673 |
| 56 | regulation of Rap GTPase activity (GO:0032317) | 2.78374336 |
| 57 | exploration behavior (GO:0035640) | 2.77571046 |
| 58 | positive regulation of Rap GTPase activity (GO:0032854) | 2.74967742 |
| 59 | macrophage activation involved in immune response (GO:0002281) | 2.72961795 |
| 60 | positive thymic T cell selection (GO:0045059) | 2.72270303 |
| 61 | histone H3-K4 trimethylation (GO:0080182) | 2.71880664 |
| 62 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.70785845 |
| 63 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.70525089 |
| 64 | germinal center formation (GO:0002467) | 2.70081144 |
| 65 | activation of protein kinase A activity (GO:0034199) | 2.69705537 |
| 66 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.68180532 |
| 67 | sodium ion export (GO:0071436) | 2.67764837 |
| 68 | auditory behavior (GO:0031223) | 2.64954002 |
| 69 | negative T cell selection (GO:0043383) | 2.63970069 |
| 70 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.63850882 |
| 71 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.63808694 |
| 72 | neuron-neuron synaptic transmission (GO:0007270) | 2.62311319 |
| 73 | response to laminar fluid shear stress (GO:0034616) | 2.61035382 |
| 74 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.59948394 |
| 75 | detection of external biotic stimulus (GO:0098581) | 2.59363962 |
| 76 | glutamate receptor signaling pathway (GO:0007215) | 2.59232821 |
| 77 | neuron cell-cell adhesion (GO:0007158) | 2.57954053 |
| 78 | positive regulation of synapse maturation (GO:0090129) | 2.57842927 |
| 79 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.55265192 |
| 80 | phospholipid dephosphorylation (GO:0046839) | 2.54265634 |
| 81 | thymic T cell selection (GO:0045061) | 2.53851332 |
| 82 | barbed-end actin filament capping (GO:0051016) | 2.53357154 |
| 83 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.50107333 |
| 84 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.48663790 |
| 85 | mitochondrion distribution (GO:0048311) | 2.48292456 |
| 86 | vesicle transport along microtubule (GO:0047496) | 2.47791580 |
| 87 | leukocyte aggregation (GO:0070486) | 2.46577912 |
| 88 | histone H3-K36 demethylation (GO:0070544) | 2.45778152 |
| 89 | neutrophil activation involved in immune response (GO:0002283) | 2.45181058 |
| 90 | negative regulation of type 2 immune response (GO:0002829) | 2.45041168 |
| 91 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.44279613 |
| 92 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.43981444 |
| 93 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.43025823 |
| 94 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.41694209 |
| 95 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.41416775 |
| 96 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.40927107 |
| 97 | signal complex assembly (GO:0007172) | 2.40883869 |
| 98 | regulation of leukocyte degranulation (GO:0043300) | 2.40698634 |
| 99 | long-term memory (GO:0007616) | 2.40414280 |
| 100 | detection of molecule of bacterial origin (GO:0032490) | 2.40324732 |
| 101 | dendritic spine morphogenesis (GO:0060997) | 2.39788968 |
| 102 | regulation of ARF GTPase activity (GO:0032312) | 2.39161632 |
| 103 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.38875497 |
| 104 | membrane depolarization during action potential (GO:0086010) | 2.37613899 |
| 105 | response to peptidoglycan (GO:0032494) | 2.37199603 |
| 106 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.37095333 |
| 107 | regulation of macrophage cytokine production (GO:0010935) | 2.36484442 |
| 108 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.36050182 |
| 109 | T cell selection (GO:0045058) | 2.35270426 |
| 110 | long-term synaptic potentiation (GO:0060291) | 2.34693526 |
| 111 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.33574398 |
| 112 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.32977005 |
| 113 | cell differentiation in hindbrain (GO:0021533) | 2.32743885 |
| 114 | regulation of postsynaptic membrane potential (GO:0060078) | 2.31572592 |
| 115 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.30560365 |
| 116 | NIK/NF-kappaB signaling (GO:0038061) | 2.29953609 |
| 117 | positive regulation of histone deacetylation (GO:0031065) | 2.29864800 |
| 118 | inositol phosphate catabolic process (GO:0071545) | 2.29786998 |
| 119 | response to interleukin-15 (GO:0070672) | 2.29593742 |
| 120 | regulation of synapse maturation (GO:0090128) | 2.29253030 |
| 121 | positive T cell selection (GO:0043368) | 2.27378478 |
| 122 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.27223333 |
| 123 | positive regulation of membrane potential (GO:0045838) | 2.27149040 |
| 124 | neurotransmitter transport (GO:0006836) | 2.27076802 |
| 125 | dendrite morphogenesis (GO:0048813) | 2.27012588 |
| 126 | protein localization to endosome (GO:0036010) | 2.26890148 |
| 127 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.25733614 |
| 128 | response to host (GO:0075136) | 2.25549643 |
| 129 | response to host defenses (GO:0052200) | 2.25549643 |
| 130 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.25549643 |
| 131 | inositol phosphate dephosphorylation (GO:0046855) | 2.25471458 |
| 132 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.25471458 |
| 133 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.24803761 |
| 134 | Golgi to endosome transport (GO:0006895) | 2.24517546 |
| 135 | detection of biotic stimulus (GO:0009595) | 2.24192750 |
| 136 | positive regulation of receptor recycling (GO:0001921) | 2.23071433 |
| 137 | potassium ion homeostasis (GO:0055075) | 2.23028550 |
| 138 | cell communication by electrical coupling (GO:0010644) | 2.22880620 |
| 139 | negative thymic T cell selection (GO:0045060) | 2.22866273 |
| 140 | dopamine receptor signaling pathway (GO:0007212) | 2.22434744 |
| 141 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.21430535 |
| 142 | regulation of neurotransmitter secretion (GO:0046928) | 2.20455394 |
| 143 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.20008130 |
| 144 | membrane hyperpolarization (GO:0060081) | 2.19759690 |
| 145 | alanine transport (GO:0032328) | 2.19251735 |
| 146 | mechanosensory behavior (GO:0007638) | 2.19245122 |
| 147 | membrane depolarization (GO:0051899) | 2.19181303 |
| 148 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.18746514 |
| 149 | positive regulation of B cell differentiation (GO:0045579) | 2.18656887 |
| 150 | embryonic process involved in female pregnancy (GO:0060136) | 2.18288174 |
| 151 | striatum development (GO:0021756) | 2.18046914 |
| 152 | negative regulation of granulocyte differentiation (GO:0030853) | 2.17900545 |
| 153 | regulation of synaptic plasticity (GO:0048167) | 2.17765075 |
| 154 | regulation of regulated secretory pathway (GO:1903305) | 2.17068505 |
| 155 | maintenance of protein location in nucleus (GO:0051457) | 2.16754566 |
| 156 | response to pheromone (GO:0019236) | 2.16570190 |
| 157 | T cell migration (GO:0072678) | 2.16330258 |
| 158 | regulation of vesicle fusion (GO:0031338) | 2.15760244 |
| 159 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.15691161 |
| 160 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.15498508 |
| 161 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.15446104 |
| 162 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.15145989 |
| 163 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.14819342 |
| 164 | regulation of type 2 immune response (GO:0002828) | 2.14528813 |
| 165 | negative regulation of T cell mediated immunity (GO:0002710) | 2.14103047 |
| 166 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.14052444 |
| 167 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.12001871 |
| 168 | cellular response to monoamine stimulus (GO:0071868) | 2.11693868 |
| 169 | cellular response to catecholamine stimulus (GO:0071870) | 2.11693868 |
| 170 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.11466770 |
| 171 | regulation of mast cell degranulation (GO:0043304) | 2.11353475 |
| 172 | response to host immune response (GO:0052572) | 2.10282933 |
| 173 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.10282933 |
| 174 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.10253435 |
| 175 | Golgi transport vesicle coating (GO:0048200) | 2.08947978 |
| 176 | COPI coating of Golgi vesicle (GO:0048205) | 2.08947978 |
| 177 | immunoglobulin mediated immune response (GO:0016064) | 2.08373895 |
| 178 | activation of JUN kinase activity (GO:0007257) | 2.07774544 |
| 179 | positive regulation of macrophage cytokine production (GO:0060907) | 2.07524547 |
| 180 | cellular response to epinephrine stimulus (GO:0071872) | 2.06608339 |
| 181 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.06468076 |
| 182 | actin filament polymerization (GO:0030041) | 2.06224974 |
| 183 | regulation of lipid kinase activity (GO:0043550) | 2.04111035 |
| 184 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.04104612 |
| 185 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.04104612 |
| 186 | type I interferon signaling pathway (GO:0060337) | 2.02245777 |
| 187 | cellular response to type I interferon (GO:0071357) | 2.02245777 |
| 188 | positive regulation of type 2 immune response (GO:0002830) | 2.01812640 |
| 189 | regulation of granulocyte differentiation (GO:0030852) | 2.01298674 |
| 190 | response to type I interferon (GO:0034340) | 2.01029176 |
| 191 | regulation of extracellular matrix disassembly (GO:0010715) | 2.00650683 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.22037522 |
| 2 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.14421219 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.84887869 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.71282042 |
| 5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.61364565 |
| 6 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.57140792 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.51565430 |
| 8 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.44534395 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.43890050 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.24073505 |
| 11 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.15658116 |
| 12 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.15210294 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.13053229 |
| 14 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.11750788 |
| 15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.10685975 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.09195044 |
| 17 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.08776410 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.02581516 |
| 19 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.98270690 |
| 20 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.94795529 |
| 21 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.93935979 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.91901129 |
| 23 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.88302013 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87535349 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.82813813 |
| 26 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.81003300 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.79862798 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78073518 |
| 29 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.75709449 |
| 30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.75709449 |
| 31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.74877407 |
| 32 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.73432592 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.72286939 |
| 34 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.72201673 |
| 35 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.71356440 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.70384635 |
| 37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.67067170 |
| 38 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.67064673 |
| 39 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.66707057 |
| 40 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.66106621 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.62902717 |
| 42 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.61130296 |
| 43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58613294 |
| 44 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.57905228 |
| 45 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.57837572 |
| 46 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.55845067 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52318951 |
| 48 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.50241348 |
| 49 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.50095205 |
| 50 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.49030412 |
| 51 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.48296269 |
| 52 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48225973 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.48197941 |
| 54 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.47849471 |
| 55 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.47842317 |
| 56 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.46899503 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.43462253 |
| 58 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42501500 |
| 59 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.42056309 |
| 60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39805607 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39576827 |
| 62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.39546940 |
| 63 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.37040569 |
| 64 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35382132 |
| 65 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34564931 |
| 66 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.33336344 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.33295466 |
| 68 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.31166408 |
| 69 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.31099396 |
| 70 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.30912570 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29658856 |
| 72 | STAT3_23295773_ChIP-Seq_U87_Human | 1.29306993 |
| 73 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29123936 |
| 74 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.28797152 |
| 75 | MAF_26560356_Chip-Seq_TH2_Human | 1.27940598 |
| 76 | KDM2B_26808549_Chip-Seq_K562_Human | 1.27771554 |
| 77 | * AR_19668381_ChIP-Seq_PC3_Human | 1.26542699 |
| 78 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26395787 |
| 79 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.25239151 |
| 80 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21859618 |
| 81 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.21078925 |
| 82 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.19783075 |
| 83 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19172484 |
| 84 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.19013454 |
| 85 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.18715038 |
| 86 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18624952 |
| 87 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.18609909 |
| 88 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.17948913 |
| 89 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.17274313 |
| 90 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.17154297 |
| 91 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16188927 |
| 92 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.16188927 |
| 93 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.15635400 |
| 94 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15391274 |
| 95 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13294333 |
| 96 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.13215109 |
| 97 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11753256 |
| 98 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.10988609 |
| 99 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.10988609 |
| 100 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.10557461 |
| 101 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.10040924 |
| 102 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09997623 |
| 103 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.09913850 |
| 104 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.09109953 |
| 105 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.08991170 |
| 106 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08875301 |
| 107 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.07504837 |
| 108 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.06724228 |
| 109 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.06418821 |
| 110 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.06184064 |
| 111 | TCF4_23295773_ChIP-Seq_U87_Human | 1.05427597 |
| 112 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.04690299 |
| 113 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03832760 |
| 114 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03389726 |
| 115 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.03229584 |
| 116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03074109 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02848074 |
| 118 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.02561630 |
| 119 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02207192 |
| 120 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02111715 |
| 121 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.01852303 |
| 122 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.01653209 |
| 123 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01612847 |
| 124 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.01472368 |
| 125 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01284542 |
| 126 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.00857629 |
| 127 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00208257 |
| 128 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00082401 |
| 129 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99710936 |
| 130 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99482621 |
| 131 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98642302 |
| 132 | AR_25329375_ChIP-Seq_VCAP_Human | 0.98321809 |
| 133 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98093063 |
| 134 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97857468 |
| 135 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.97604139 |
| 136 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.97540090 |
| 137 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97150674 |
| 138 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97025362 |
| 139 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.97006986 |
| 140 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96687278 |
| 141 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.96517354 |
| 142 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.96070064 |
| 143 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94317336 |
| 144 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94166325 |
| 145 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.93996054 |
| 146 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.93210598 |
| 147 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.92660113 |
| 148 | P300_19829295_ChIP-Seq_ESCs_Human | 0.91774025 |
| 149 | MYB_26560356_Chip-Seq_TH2_Human | 0.91552257 |
| 150 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91328177 |
| 151 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.90218911 |
| 152 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.90066047 |
| 153 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.89770964 |
| 154 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89585163 |
| 155 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88447274 |
| 156 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86944091 |
| 157 | TP53_16413492_ChIP-PET_HCT116_Human | 0.86496846 |
| 158 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.86191778 |
| 159 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.86176990 |
| 160 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.85366768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.56313518 |
| 2 | MP0000569_abnormal_digit_pigmentation | 4.14269847 |
| 3 | MP0003183_abnormal_peptide_metabolism | 3.67582947 |
| 4 | MP0003436_decreased_susceptibility_to | 3.52402318 |
| 5 | MP0003303_peritoneal_inflammation | 3.03264260 |
| 6 | MP0003724_increased_susceptibility_to | 2.93289087 |
| 7 | MP0003880_abnormal_central_pattern | 2.92018285 |
| 8 | MP0005423_abnormal_somatic_nervous | 2.84700204 |
| 9 | MP0003787_abnormal_imprinting | 2.81825521 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 2.78439468 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.67833304 |
| 12 | MP0001958_emphysema | 2.50756346 |
| 13 | MP0008961_abnormal_basal_metabolism | 2.45591167 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.40585840 |
| 15 | MP0002254_reproductive_system_inflammat | 2.38587312 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.36034737 |
| 17 | MP0009046_muscle_twitch | 2.32078271 |
| 18 | MP0004858_abnormal_nervous_system | 2.25501608 |
| 19 | MP0002063_abnormal_learning/memory/cond | 2.15344354 |
| 20 | MP0002064_seizures | 2.13282837 |
| 21 | MP0005646_abnormal_pituitary_gland | 2.13217555 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 2.12089253 |
| 23 | MP0009278_abnormal_bone_marrow | 2.05841236 |
| 24 | MP0009745_abnormal_behavioral_response | 1.99269196 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.99125942 |
| 26 | MP0003122_maternal_imprinting | 1.95575684 |
| 27 | MP0003279_aneurysm | 1.95555274 |
| 28 | MP0003828_pulmonary_edema | 1.95492087 |
| 29 | MP0008260_abnormal_autophagy | 1.95401039 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.95316851 |
| 31 | MP0009840_abnormal_foam_cell | 1.95175284 |
| 32 | MP0009780_abnormal_chondrocyte_physiolo | 1.92107200 |
| 33 | MP0001968_abnormal_touch/_nociception | 1.91931992 |
| 34 | MP0002419_abnormal_innate_immunity | 1.90244027 |
| 35 | MP0002572_abnormal_emotion/affect_behav | 1.89030854 |
| 36 | MP0004270_analgesia | 1.84291655 |
| 37 | MP0008438_abnormal_cutaneous_collagen | 1.83128801 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.82591108 |
| 39 | MP0005645_abnormal_hypothalamus_physiol | 1.82281120 |
| 40 | MP0004947_skin_inflammation | 1.77620499 |
| 41 | MP0005000_abnormal_immune_tolerance | 1.77423338 |
| 42 | MP0003091_abnormal_cell_migration | 1.76414078 |
| 43 | MP0001486_abnormal_startle_reflex | 1.74473298 |
| 44 | MP0005499_abnormal_olfactory_system | 1.73710729 |
| 45 | MP0005394_taste/olfaction_phenotype | 1.73710729 |
| 46 | MP0005025_abnormal_response_to | 1.72671532 |
| 47 | MP0003329_amyloid_beta_deposits | 1.72666521 |
| 48 | MP0002396_abnormal_hematopoietic_system | 1.70919174 |
| 49 | MP0002909_abnormal_adrenal_gland | 1.61026433 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.59171672 |
| 51 | MP0002272_abnormal_nervous_system | 1.55441152 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.53361526 |
| 53 | MP0008569_lethality_at_weaning | 1.51064250 |
| 54 | MP0003566_abnormal_cell_adhesion | 1.50168490 |
| 55 | MP0002405_respiratory_system_inflammati | 1.48923071 |
| 56 | MP0000604_amyloidosis | 1.47981142 |
| 57 | MP0004510_myositis | 1.45775206 |
| 58 | MP0005409_darkened_coat_color | 1.42776635 |
| 59 | MP0001501_abnormal_sleep_pattern | 1.41354837 |
| 60 | MP0002736_abnormal_nociception_after | 1.40695375 |
| 61 | MP0002733_abnormal_thermal_nociception | 1.39819515 |
| 62 | MP0005310_abnormal_salivary_gland | 1.38006635 |
| 63 | MP0003121_genomic_imprinting | 1.37167318 |
| 64 | MP0002184_abnormal_innervation | 1.36310686 |
| 65 | MP0002163_abnormal_gland_morphology | 1.34758191 |
| 66 | MP0002067_abnormal_sensory_capabilities | 1.34667453 |
| 67 | MP0004811_abnormal_neuron_physiology | 1.34280027 |
| 68 | MP0005451_abnormal_body_composition | 1.33387985 |
| 69 | MP0000778_abnormal_nervous_system | 1.32928003 |
| 70 | MP0005174_abnormal_tail_pigmentation | 1.30476089 |
| 71 | MP0002557_abnormal_social/conspecific_i | 1.30191837 |
| 72 | MP0005671_abnormal_response_to | 1.29222749 |
| 73 | MP0001970_abnormal_pain_threshold | 1.26941084 |
| 74 | MP0002734_abnormal_mechanical_nocicepti | 1.24171315 |
| 75 | MP0005397_hematopoietic_system_phenotyp | 1.21290669 |
| 76 | MP0001545_abnormal_hematopoietic_system | 1.21290669 |
| 77 | MP0000955_abnormal_spinal_cord | 1.19134930 |
| 78 | MP0002277_abnormal_respiratory_mucosa | 1.18451197 |
| 79 | MP0010155_abnormal_intestine_physiology | 1.18393002 |
| 80 | MP0001835_abnormal_antigen_presentation | 1.17671943 |
| 81 | MP0000858_altered_metastatic_potential | 1.17041614 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 1.16268443 |
| 83 | MP0001348_abnormal_lacrimal_gland | 1.15744261 |
| 84 | MP0000751_myopathy | 1.15485989 |
| 85 | MP0005666_abnormal_adipose_tissue | 1.14058439 |
| 86 | MP0001849_ear_inflammation | 1.13880821 |
| 87 | MP0006082_CNS_inflammation | 1.13815293 |
| 88 | MP0001851_eye_inflammation | 1.12451973 |
| 89 | MP0009785_altered_susceptibility_to | 1.11973410 |
| 90 | MP0006292_abnormal_olfactory_placode | 1.11449461 |
| 91 | MP0002735_abnormal_chemical_nociception | 1.10237683 |
| 92 | MP0005379_endocrine/exocrine_gland_phen | 1.09609814 |
| 93 | MP0005386_behavior/neurological_phenoty | 1.09236634 |
| 94 | MP0004924_abnormal_behavior | 1.09236634 |
| 95 | MP0010386_abnormal_urinary_bladder | 1.08273171 |
| 96 | MP0001790_abnormal_immune_system | 1.05933508 |
| 97 | MP0005387_immune_system_phenotype | 1.05933508 |
| 98 | MP0001270_distended_abdomen | 1.04946877 |
| 99 | MP0002148_abnormal_hypersensitivity_rea | 1.04473670 |
| 100 | MP0002882_abnormal_neuron_morphology | 1.03297913 |
| 101 | MP0002933_joint_inflammation | 1.00760126 |
| 102 | MP0004264_abnormal_extraembryonic_tissu | 1.00147359 |
| 103 | MP0000920_abnormal_myelination | 1.00126297 |
| 104 | MP0004885_abnormal_endolymph | 0.98097558 |
| 105 | MP0001502_abnormal_circadian_rhythm | 0.97933350 |
| 106 | MP0001984_abnormal_olfaction | 0.97091955 |
| 107 | MP0005275_abnormal_skin_tensile | 0.96993219 |
| 108 | MP0005390_skeleton_phenotype | 0.96949984 |
| 109 | MP0000767_abnormal_smooth_muscle | 0.96271161 |
| 110 | MP0000015_abnormal_ear_pigmentation | 0.94800186 |
| 111 | MP0002971_abnormal_brown_adipose | 0.94226805 |
| 112 | MP0002877_abnormal_melanocyte_morpholog | 0.93921139 |
| 113 | MP0000685_abnormal_immune_system | 0.93205781 |
| 114 | MP0005375_adipose_tissue_phenotype | 0.93130598 |
| 115 | MP0004130_abnormal_muscle_cell | 0.92825576 |
| 116 | MP0003633_abnormal_nervous_system | 0.92583183 |
| 117 | MP0003075_altered_response_to | 0.91923053 |
| 118 | MP0008874_decreased_physiological_sensi | 0.90936089 |
| 119 | MP0001845_abnormal_inflammatory_respons | 0.89544306 |
| 120 | MP0000249_abnormal_blood_vessel | 0.89093727 |
| 121 | MP0005551_abnormal_eye_electrophysiolog | 0.88794364 |
| 122 | MP0002133_abnormal_respiratory_system | 0.88675088 |
| 123 | MP0005388_respiratory_system_phenotype | 0.88675088 |
| 124 | MP0005503_abnormal_tendon_morphology | 0.88456894 |
| 125 | MP0003879_abnormal_hair_cell | 0.87522209 |
| 126 | MP0001800_abnormal_humoral_immune | 0.87319553 |
| 127 | MP0000371_diluted_coat_color | 0.85976669 |
| 128 | MP0002166_altered_tumor_susceptibility | 0.85302993 |
| 129 | MP0003045_fibrosis | 0.85056314 |
| 130 | MP0000703_abnormal_thymus_morphology | 0.84835824 |
| 131 | MP0002009_preneoplasia | 0.83274647 |
| 132 | MP0000759_abnormal_skeletal_muscle | 0.81543168 |
| 133 | MP0009384_cardiac_valve_regurgitation | 0.81255985 |
| 134 | MP0002429_abnormal_blood_cell | 0.81060121 |
| 135 | MP0001440_abnormal_grooming_behavior | 0.80252827 |
| 136 | MP0003866_abnormal_defecation | 0.80035308 |
| 137 | MP0001819_abnormal_immune_cell | 0.79567132 |
| 138 | MP0002066_abnormal_motor_capabilities/c | 0.78882324 |
| 139 | MP0002420_abnormal_adaptive_immunity | 0.78622246 |
| 140 | MP0003690_abnormal_glial_cell | 0.78412890 |
| 141 | MP0004142_abnormal_muscle_tone | 0.77579180 |
| 142 | MP0003453_abnormal_keratinocyte_physiol | 0.76535791 |
| 143 | MP0004883_abnormal_blood_vessel | 0.76486082 |
| 144 | MP0002229_neurodegeneration | 0.75850988 |
| 145 | MP0002722_abnormal_immune_system | 0.75631973 |
| 146 | MP0002069_abnormal_eating/drinking_beha | 0.74875952 |
| 147 | MP0006276_abnormal_autonomic_nervous | 0.74417145 |
| 148 | MP0000689_abnormal_spleen_morphology | 0.74265944 |
| 149 | MP0001346_abnormal_lacrimal_gland | 0.73902272 |
| 150 | MP0002452_abnormal_antigen_presenting | 0.73857901 |
| 151 | MP0002398_abnormal_bone_marrow | 0.73093378 |
| 152 | MP0004808_abnormal_hematopoietic_stem | 0.72075894 |
| 153 | MP0002295_abnormal_pulmonary_circulatio | 0.72012179 |
| 154 | MP0005535_abnormal_body_temperature | 0.69739527 |
| 155 | MP0003634_abnormal_glial_cell | 0.69736619 |
| 156 | MP0000733_abnormal_muscle_development | 0.69365005 |
| 157 | MP0008004_abnormal_stomach_pH | 0.69358814 |
| 158 | MP0003795_abnormal_bone_structure | 0.69192148 |
| 159 | MP0002723_abnormal_immune_serum | 0.69105322 |
| 160 | MP0008789_abnormal_olfactory_epithelium | 0.67827575 |
| 161 | MP0003631_nervous_system_phenotype | 0.67052645 |
| 162 | MP0004087_abnormal_muscle_fiber | 0.67013700 |
| 163 | MP0000716_abnormal_immune_system | 0.66456325 |
| 164 | MP0001873_stomach_inflammation | 0.66252336 |
| 165 | MP0002095_abnormal_skin_pigmentation | 0.66046711 |
| 166 | MP0006138_congestive_heart_failure | 0.65911840 |
| 167 | MP0005058_abnormal_lysosome_morphology | 0.65255885 |
| 168 | MP0002152_abnormal_brain_morphology | 0.65129882 |
| 169 | MP0000747_muscle_weakness | 0.64655110 |
| 170 | MP0001986_abnormal_taste_sensitivity | 0.64030948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Epileptic encephalopathy (HP:0200134) | 4.15865183 |
| 2 | Febrile seizures (HP:0002373) | 4.05804966 |
| 3 | Eczematoid dermatitis (HP:0000976) | 3.67024459 |
| 4 | Focal seizures (HP:0007359) | 3.51201785 |
| 5 | Focal motor seizures (HP:0011153) | 3.46273240 |
| 6 | Supranuclear gaze palsy (HP:0000605) | 3.30287578 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.27860833 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.27860833 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 3.27860833 |
| 10 | Obstructive sleep apnea (HP:0002870) | 3.17580536 |
| 11 | Volvulus (HP:0002580) | 3.05775267 |
| 12 | Protrusio acetabuli (HP:0003179) | 3.00935147 |
| 13 | Macroorchidism (HP:0000053) | 2.95968384 |
| 14 | Dysostosis multiplex (HP:0000943) | 2.84776614 |
| 15 | Visual hallucinations (HP:0002367) | 2.82590841 |
| 16 | Increased variability in muscle fiber diameter (HP:0003557) | 2.65527362 |
| 17 | Mucopolysacchariduria (HP:0008155) | 2.64700666 |
| 18 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.64700666 |
| 19 | Spontaneous hematomas (HP:0007420) | 2.63709673 |
| 20 | Abnormality of the lower motor neuron (HP:0002366) | 2.58543860 |
| 21 | Open mouth (HP:0000194) | 2.58453383 |
| 22 | Papilledema (HP:0001085) | 2.58218568 |
| 23 | Failure to thrive in infancy (HP:0001531) | 2.58032852 |
| 24 | Asymmetric septal hypertrophy (HP:0001670) | 2.57607450 |
| 25 | Abnormality of the astrocytes (HP:0100707) | 2.57027728 |
| 26 | Astrocytoma (HP:0009592) | 2.57027728 |
| 27 | Dialeptic seizures (HP:0011146) | 2.56747834 |
| 28 | Progressive cerebellar ataxia (HP:0002073) | 2.56529858 |
| 29 | Myositis (HP:0100614) | 2.55506470 |
| 30 | Abnormality of macrophages (HP:0004311) | 2.52452462 |
| 31 | Postural instability (HP:0002172) | 2.50573418 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 2.48699015 |
| 33 | Cellulitis (HP:0100658) | 2.44399870 |
| 34 | Hand muscle atrophy (HP:0009130) | 2.43838896 |
| 35 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.42369878 |
| 36 | Neoplasm of the heart (HP:0100544) | 2.42177493 |
| 37 | Recurrent abscess formation (HP:0002722) | 2.42122882 |
| 38 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.39128668 |
| 39 | Thin bony cortex (HP:0002753) | 2.37064810 |
| 40 | Cervical subluxation (HP:0003308) | 2.35816093 |
| 41 | Atonic seizures (HP:0010819) | 2.35506864 |
| 42 | Increased IgE level (HP:0003212) | 2.34722282 |
| 43 | Neurofibrillary tangles (HP:0002185) | 2.34112978 |
| 44 | Generalized tonic-clonic seizures (HP:0002069) | 2.33781226 |
| 45 | Mutism (HP:0002300) | 2.32862335 |
| 46 | Depression (HP:0000716) | 2.32653908 |
| 47 | Excessive salivation (HP:0003781) | 2.31833427 |
| 48 | Drooling (HP:0002307) | 2.31833427 |
| 49 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.31598188 |
| 50 | Aortic aneurysm (HP:0004942) | 2.30384772 |
| 51 | Truncal ataxia (HP:0002078) | 2.29466852 |
| 52 | Impaired smooth pursuit (HP:0007772) | 2.27850213 |
| 53 | Neuronal loss in central nervous system (HP:0002529) | 2.26593832 |
| 54 | Orchitis (HP:0100796) | 2.24102810 |
| 55 | Genetic anticipation (HP:0003743) | 2.22618599 |
| 56 | Cerebral aneurysm (HP:0004944) | 2.22560250 |
| 57 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.22551552 |
| 58 | Mediastinal lymphadenopathy (HP:0100721) | 2.21003708 |
| 59 | Hemiplegia (HP:0002301) | 2.20798384 |
| 60 | Gingivitis (HP:0000230) | 2.20700357 |
| 61 | Absence seizures (HP:0002121) | 2.20643028 |
| 62 | Abnormal hair whorl (HP:0010721) | 2.19321544 |
| 63 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.17708834 |
| 64 | Peritonitis (HP:0002586) | 2.16522263 |
| 65 | Absent speech (HP:0001344) | 2.16033216 |
| 66 | Inappropriate behavior (HP:0000719) | 2.10760553 |
| 67 | Vascular tortuosity (HP:0004948) | 2.10427565 |
| 68 | Absent frontal sinuses (HP:0002688) | 2.09493614 |
| 69 | Apathy (HP:0000741) | 2.09226534 |
| 70 | Increased connective tissue (HP:0009025) | 2.07105030 |
| 71 | Emphysema (HP:0002097) | 2.05822947 |
| 72 | Hyperventilation (HP:0002883) | 2.05180345 |
| 73 | Ependymoma (HP:0002888) | 2.04372001 |
| 74 | Generalized hypotonia (HP:0001290) | 2.04284507 |
| 75 | Interstitial pulmonary disease (HP:0006530) | 2.04103139 |
| 76 | Protruding tongue (HP:0010808) | 2.04084794 |
| 77 | Difficulty running (HP:0009046) | 2.03854704 |
| 78 | Hip dysplasia (HP:0001385) | 2.03639508 |
| 79 | Myokymia (HP:0002411) | 2.03408475 |
| 80 | Distal upper limb amyotrophy (HP:0007149) | 2.02125986 |
| 81 | Upper limb amyotrophy (HP:0009129) | 2.02125986 |
| 82 | Aneurysm (HP:0002617) | 2.01746495 |
| 83 | Prolonged bleeding time (HP:0003010) | 2.01264577 |
| 84 | Arterial tortuosity (HP:0005116) | 2.00945596 |
| 85 | Dilatation of the ascending aorta (HP:0005111) | 2.00087809 |
| 86 | Action tremor (HP:0002345) | 1.98920266 |
| 87 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.98829711 |
| 88 | Tapered finger (HP:0001182) | 1.98429400 |
| 89 | Hemiparesis (HP:0001269) | 1.98118834 |
| 90 | Loss of speech (HP:0002371) | 1.97052306 |
| 91 | Cerebral inclusion bodies (HP:0100314) | 1.95970229 |
| 92 | Spinal canal stenosis (HP:0003416) | 1.95872252 |
| 93 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.95808471 |
| 94 | Gaze-evoked nystagmus (HP:0000640) | 1.95625354 |
| 95 | Gastrointestinal stroma tumor (HP:0100723) | 1.95365842 |
| 96 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.93234234 |
| 97 | Recurrent fungal infections (HP:0002841) | 1.91812639 |
| 98 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.91437383 |
| 99 | Diminished motivation (HP:0000745) | 1.89633851 |
| 100 | Recurrent cutaneous fungal infections (HP:0011370) | 1.89067044 |
| 101 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.89067044 |
| 102 | Mitral regurgitation (HP:0001653) | 1.87799478 |
| 103 | Panhypogammaglobulinemia (HP:0003139) | 1.87669438 |
| 104 | Increased cerebral lipofuscin (HP:0011813) | 1.86884713 |
| 105 | Amblyopia (HP:0000646) | 1.86700402 |
| 106 | Tented upper lip vermilion (HP:0010804) | 1.85892764 |
| 107 | Abnormality of binocular vision (HP:0011514) | 1.85138360 |
| 108 | Diplopia (HP:0000651) | 1.85138360 |
| 109 | Iris hypopigmentation (HP:0007730) | 1.84973992 |
| 110 | Resting tremor (HP:0002322) | 1.83232907 |
| 111 | Abnormality of the corticospinal tract (HP:0002492) | 1.82676626 |
| 112 | Systemic lupus erythematosus (HP:0002725) | 1.82383383 |
| 113 | Exotropia (HP:0000577) | 1.82035312 |
| 114 | Hypercortisolism (HP:0001578) | 1.81753133 |
| 115 | Exercise-induced myalgia (HP:0003738) | 1.80744490 |
| 116 | Abnormal eating behavior (HP:0100738) | 1.79994029 |
| 117 | Retrobulbar optic neuritis (HP:0100654) | 1.79964804 |
| 118 | Optic neuritis (HP:0100653) | 1.79964804 |
| 119 | Bilateral microphthalmos (HP:0007633) | 1.79853227 |
| 120 | Joint stiffness (HP:0001387) | 1.79404207 |
| 121 | Ocular albinism (HP:0001107) | 1.78792481 |
| 122 | Broad-based gait (HP:0002136) | 1.78532508 |
| 123 | Gingival bleeding (HP:0000225) | 1.78479494 |
| 124 | Poor eye contact (HP:0000817) | 1.78236468 |
| 125 | Meningitis (HP:0001287) | 1.78235675 |
| 126 | Gastrointestinal inflammation (HP:0004386) | 1.78202823 |
| 127 | Abnormality of the fingertips (HP:0001211) | 1.78189566 |
| 128 | Aortic dissection (HP:0002647) | 1.78029968 |
| 129 | Spondylolisthesis (HP:0003302) | 1.77031790 |
| 130 | Abnormal social behavior (HP:0012433) | 1.76971167 |
| 131 | Impaired social interactions (HP:0000735) | 1.76971167 |
| 132 | Recurrent skin infections (HP:0001581) | 1.75995340 |
| 133 | Polyphagia (HP:0002591) | 1.75965907 |
| 134 | Epistaxis (HP:0000421) | 1.75652227 |
| 135 | Bradykinesia (HP:0002067) | 1.75323192 |
| 136 | Amyloidosis (HP:0011034) | 1.75275669 |
| 137 | Gastrointestinal infarctions (HP:0005244) | 1.75163184 |
| 138 | Glioma (HP:0009733) | 1.75061218 |
| 139 | Pointed chin (HP:0000307) | 1.74384473 |
| 140 | Ankle clonus (HP:0011448) | 1.73832435 |
| 141 | Vasculitis (HP:0002633) | 1.73795961 |
| 142 | Hyperacusis (HP:0010780) | 1.73493397 |
| 143 | Abnormality of the peritoneum (HP:0002585) | 1.72532922 |
| 144 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.71876554 |
| 145 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.71876554 |
| 146 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.71876554 |
| 147 | Purpura (HP:0000979) | 1.71840699 |
| 148 | Distal lower limb amyotrophy (HP:0008944) | 1.71751043 |
| 149 | Vertebral compression fractures (HP:0002953) | 1.71701796 |
| 150 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.70786717 |
| 151 | Hepatoblastoma (HP:0002884) | 1.70590923 |
| 152 | Lower limb muscle weakness (HP:0007340) | 1.70200955 |
| 153 | Chest pain (HP:0100749) | 1.69257556 |
| 154 | Spastic gait (HP:0002064) | 1.69044537 |
| 155 | Colitis (HP:0002583) | 1.68883434 |
| 156 | Slow saccadic eye movements (HP:0000514) | 1.68701665 |
| 157 | Hyporeflexia of lower limbs (HP:0002600) | 1.68678541 |
| 158 | Type 1 muscle fiber predominance (HP:0003803) | 1.68486987 |
| 159 | Aqueductal stenosis (HP:0002410) | 1.68169312 |
| 160 | Syringomyelia (HP:0003396) | 1.67465266 |
| 161 | Spinal cord lesions (HP:0100561) | 1.67465266 |
| 162 | Broad metatarsal (HP:0001783) | 1.67008692 |
| 163 | Polycythemia (HP:0001901) | 1.66977863 |
| 164 | Chronic obstructive pulmonary disease (HP:0006510) | 1.66930264 |
| 165 | Obstructive lung disease (HP:0006536) | 1.66930264 |
| 166 | Intention tremor (HP:0002080) | 1.66902613 |
| 167 | Peripheral hypomyelination (HP:0007182) | 1.66759928 |
| 168 | Restrictive lung disease (HP:0002091) | 1.66601447 |
| 169 | Inflammation of the large intestine (HP:0002037) | 1.66221223 |
| 170 | Abnormality of the periventricular white matter (HP:0002518) | 1.65831718 |
| 171 | Abnormality of chromosome segregation (HP:0002916) | 1.65123074 |
| 172 | Epileptiform EEG discharges (HP:0011182) | 1.64741073 |
| 173 | EEG with generalized epileptiform discharges (HP:0011198) | 1.64553733 |
| 174 | Premature loss of primary teeth (HP:0006323) | 1.63534273 |
| 175 | Premature rupture of membranes (HP:0001788) | 1.63082936 |
| 176 | Hypoplasia of the iris (HP:0007676) | 1.63055469 |
| 177 | Akinesia (HP:0002304) | 1.63014566 |
| 178 | Lower limb amyotrophy (HP:0007210) | 1.61883646 |
| 179 | Congenital stationary night blindness (HP:0007642) | 1.60456012 |
| 180 | Supernumerary nipples (HP:0002558) | 1.60147253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 2.96348240 |
| 2 | MAP3K13 | 2.76318942 |
| 3 | MAP3K9 | 2.70930122 |
| 4 | CDK12 | 2.60372790 |
| 5 | INSRR | 2.57210289 |
| 6 | NTRK2 | 2.39965252 |
| 7 | TRIB3 | 2.33820536 |
| 8 | MAP3K4 | 2.14053078 |
| 9 | MARK1 | 2.09546538 |
| 10 | RIPK1 | 1.97853029 |
| 11 | SIK1 | 1.93385448 |
| 12 | MAP4K1 | 1.93238816 |
| 13 | MAP2K7 | 1.86046016 |
| 14 | CAMK1G | 1.80978350 |
| 15 | SIK2 | 1.77559407 |
| 16 | MAP2K4 | 1.77445809 |
| 17 | PRPF4B | 1.76424974 |
| 18 | CDC42BPA | 1.74982105 |
| 19 | CSF1R | 1.74632101 |
| 20 | CAMK1D | 1.73981625 |
| 21 | GRK5 | 1.72612978 |
| 22 | MAP2K3 | 1.65493432 |
| 23 | EPHA4 | 1.61042155 |
| 24 | CAMKK2 | 1.57816735 |
| 25 | BLK | 1.54507639 |
| 26 | RIPK4 | 1.53701378 |
| 27 | BRD4 | 1.52973856 |
| 28 | FGFR4 | 1.50567155 |
| 29 | CAMKK1 | 1.42801794 |
| 30 | CCNB1 | 1.42668257 |
| 31 | ZAP70 | 1.41970382 |
| 32 | MARK2 | 1.38839626 |
| 33 | HIPK2 | 1.34678730 |
| 34 | MAP3K7 | 1.34155187 |
| 35 | NTRK1 | 1.33110756 |
| 36 | FES | 1.32346374 |
| 37 | JAK1 | 1.31586905 |
| 38 | FGFR3 | 1.27728828 |
| 39 | PDGFRA | 1.27159407 |
| 40 | SIK3 | 1.23230629 |
| 41 | ERN1 | 1.22809059 |
| 42 | KIT | 1.22497774 |
| 43 | DAPK2 | 1.22065708 |
| 44 | TTN | 1.21744509 |
| 45 | GRK6 | 1.20250523 |
| 46 | CSK | 1.20082357 |
| 47 | PRKD2 | 1.19257990 |
| 48 | TNIK | 1.19052605 |
| 49 | KSR1 | 1.15685385 |
| 50 | CASK | 1.15173973 |
| 51 | PAK6 | 1.13631840 |
| 52 | MINK1 | 1.12805360 |
| 53 | MATK | 1.09669608 |
| 54 | TYRO3 | 1.08883727 |
| 55 | CAMK4 | 1.07923400 |
| 56 | MAPK7 | 1.06607345 |
| 57 | IRAK4 | 1.03058894 |
| 58 | MAP3K6 | 1.03034696 |
| 59 | RET | 1.02688106 |
| 60 | ICK | 1.02445484 |
| 61 | JAK3 | 1.01223483 |
| 62 | SYK | 0.99809263 |
| 63 | CDK5 | 0.99116336 |
| 64 | DYRK1B | 0.96403500 |
| 65 | CAMK1 | 0.94630569 |
| 66 | GRK1 | 0.90542278 |
| 67 | WNK1 | 0.90261212 |
| 68 | KSR2 | 0.90248187 |
| 69 | MAP3K3 | 0.90089322 |
| 70 | NEK9 | 0.89420229 |
| 71 | ADRBK2 | 0.89173460 |
| 72 | MAP3K1 | 0.86425459 |
| 73 | DDR2 | 0.85144383 |
| 74 | PRKD3 | 0.81680139 |
| 75 | TYK2 | 0.81161241 |
| 76 | MAPK13 | 0.79157947 |
| 77 | SMG1 | 0.78981412 |
| 78 | IKBKE | 0.74667663 |
| 79 | PDPK1 | 0.74204832 |
| 80 | MAP3K10 | 0.74001692 |
| 81 | MAP3K11 | 0.73635801 |
| 82 | TGFBR2 | 0.73468904 |
| 83 | EEF2K | 0.72903008 |
| 84 | HCK | 0.72895194 |
| 85 | FGR | 0.72649453 |
| 86 | TAOK1 | 0.72302826 |
| 87 | PIK3CG | 0.72155502 |
| 88 | DAPK1 | 0.71894961 |
| 89 | SGK2 | 0.71869563 |
| 90 | JAK2 | 0.71045849 |
| 91 | PDGFRB | 0.70929656 |
| 92 | PHKG1 | 0.70214843 |
| 93 | PHKG2 | 0.70214843 |
| 94 | MOS | 0.68724757 |
| 95 | SGK3 | 0.68451135 |
| 96 | PRKCH | 0.68433974 |
| 97 | DMPK | 0.65905425 |
| 98 | PTK6 | 0.65808598 |
| 99 | STK11 | 0.65439693 |
| 100 | STK38 | 0.64717062 |
| 101 | TAOK3 | 0.63543782 |
| 102 | MAPK12 | 0.62980762 |
| 103 | MAP3K14 | 0.62336951 |
| 104 | MTOR | 0.61284431 |
| 105 | CHUK | 0.61178347 |
| 106 | ITK | 0.60301831 |
| 107 | TNK2 | 0.59068751 |
| 108 | PDK1 | 0.58747557 |
| 109 | GRK7 | 0.58384367 |
| 110 | MAPK10 | 0.57940216 |
| 111 | BTK | 0.57653033 |
| 112 | EPHB1 | 0.57435416 |
| 113 | IKBKB | 0.57114565 |
| 114 | CDK19 | 0.56965948 |
| 115 | SGK1 | 0.56116952 |
| 116 | PLK2 | 0.55840733 |
| 117 | TAOK2 | 0.54671332 |
| 118 | PRKAA1 | 0.53691566 |
| 119 | BMPR2 | 0.53659946 |
| 120 | PRKCG | 0.53358008 |
| 121 | RPS6KA2 | 0.53253073 |
| 122 | LYN | 0.53033453 |
| 123 | MAP2K2 | 0.52897681 |
| 124 | RPS6KC1 | 0.51885764 |
| 125 | RPS6KL1 | 0.51885764 |
| 126 | TESK1 | 0.51698519 |
| 127 | CDK6 | 0.50003817 |
| 128 | MARK3 | 0.49520448 |
| 129 | EPHA3 | 0.49394670 |
| 130 | LRRK2 | 0.48806331 |
| 131 | PRKAA2 | 0.47790468 |
| 132 | UHMK1 | 0.47500934 |
| 133 | ALK | 0.47485359 |
| 134 | PRKD1 | 0.47241239 |
| 135 | SGK223 | 0.47155830 |
| 136 | SGK494 | 0.47155830 |
| 137 | PKN1 | 0.45775283 |
| 138 | NEK6 | 0.45614389 |
| 139 | CLK1 | 0.44683810 |
| 140 | DYRK1A | 0.44642658 |
| 141 | ADRBK1 | 0.40097296 |
| 142 | MAPK8 | 0.39176552 |
| 143 | TBK1 | 0.37458036 |
| 144 | RPS6KA3 | 0.36584827 |
| 145 | FYN | 0.36370986 |
| 146 | LCK | 0.36354336 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.07785661 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.07119835 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.01995537 |
| 4 | Morphine addiction_Homo sapiens_hsa05032 | 1.93059297 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 1.86760894 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 1.85663047 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 1.81017875 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.77243128 |
| 9 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.75912694 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.72950557 |
| 11 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.66329642 |
| 12 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.63556451 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.61379911 |
| 14 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.54861122 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.50821945 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.48602718 |
| 17 | Long-term potentiation_Homo sapiens_hsa04720 | 1.48422519 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.42214311 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.36219465 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.35309876 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.34043915 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.33370049 |
| 23 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.33180615 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.32363220 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.32107645 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.29567114 |
| 27 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.27626973 |
| 28 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26428762 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.26262995 |
| 30 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.26116221 |
| 31 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.24951344 |
| 32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.23794931 |
| 33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.20725285 |
| 34 | Long-term depression_Homo sapiens_hsa04730 | 1.19347837 |
| 35 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.18909671 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17770138 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17405713 |
| 38 | Cocaine addiction_Homo sapiens_hsa05030 | 1.14689337 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.14108564 |
| 40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.13545922 |
| 41 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.11265911 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.10743875 |
| 43 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.10538847 |
| 44 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.06653107 |
| 45 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.05663396 |
| 46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.05336157 |
| 47 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.05303885 |
| 48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04090155 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04008103 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.03683839 |
| 51 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.02847604 |
| 52 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.02313420 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.01654269 |
| 54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.01557916 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00462665 |
| 56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.98768508 |
| 57 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.98500252 |
| 58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.98389124 |
| 59 | Hepatitis B_Homo sapiens_hsa05161 | 0.98252103 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.98053512 |
| 61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.96639536 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95157351 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.93844577 |
| 64 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.93221281 |
| 65 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.90963314 |
| 66 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.89980741 |
| 67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.89804125 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89591721 |
| 69 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.89347567 |
| 70 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.88935771 |
| 71 | Focal adhesion_Homo sapiens_hsa04510 | 0.88729192 |
| 72 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.88271940 |
| 73 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.88107380 |
| 74 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87804699 |
| 75 | Allograft rejection_Homo sapiens_hsa05330 | 0.87612897 |
| 76 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.87406150 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86524630 |
| 78 | Gap junction_Homo sapiens_hsa04540 | 0.86252117 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85945581 |
| 80 | Malaria_Homo sapiens_hsa05144 | 0.84970520 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.84870811 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 0.82612543 |
| 83 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.81942811 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.81859332 |
| 85 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.81724494 |
| 86 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.81407056 |
| 87 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80736623 |
| 88 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.78057643 |
| 89 | Axon guidance_Homo sapiens_hsa04360 | 0.76461291 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74896860 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73810990 |
| 92 | Colorectal cancer_Homo sapiens_hsa05210 | 0.73458769 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.73434382 |
| 94 | Pertussis_Homo sapiens_hsa05133 | 0.73428032 |
| 95 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71457592 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70731218 |
| 97 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70180303 |
| 98 | Lysosome_Homo sapiens_hsa04142 | 0.69688590 |
| 99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.68872031 |
| 100 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68856899 |
| 101 | Prostate cancer_Homo sapiens_hsa05215 | 0.68678636 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.68440227 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.67996331 |
| 104 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67540189 |
| 105 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.67514925 |
| 106 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.67065078 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.66826773 |
| 108 | Salmonella infection_Homo sapiens_hsa05132 | 0.66465818 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.66203350 |
| 110 | Tuberculosis_Homo sapiens_hsa05152 | 0.65512582 |
| 111 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.64350141 |
| 112 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63781743 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63536039 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63473872 |
| 115 | Apoptosis_Homo sapiens_hsa04210 | 0.62535502 |
| 116 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.62314141 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.61927511 |
| 118 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61177871 |
| 119 | Melanogenesis_Homo sapiens_hsa04916 | 0.59315221 |
| 120 | Phototransduction_Homo sapiens_hsa04744 | 0.59238409 |
| 121 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58347807 |
| 122 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.57840279 |
| 123 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57423067 |
| 124 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54760074 |
| 125 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.53178167 |
| 126 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52891173 |
| 127 | Measles_Homo sapiens_hsa05162 | 0.52094967 |
| 128 | Insulin resistance_Homo sapiens_hsa04931 | 0.51412295 |
| 129 | Influenza A_Homo sapiens_hsa05164 | 0.51320471 |
| 130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51066406 |
| 131 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50342158 |
| 132 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50152627 |

